Cited 0 times in

InIncidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019

Authors
 Marco Solmi  ;  Georgios Seitidis  ;  Dimitris Mavridis  ;  Christoph U Correll  ;  Elena Dragioti  ;  Synthia Guimond  ;  Lauri Tuominen  ;  Aroldo Dargél  ;  Andre F Carvalho  ;  Michele Fornaro  ;  Michael Maes  ;  Francesco Monaco  ;  Minjin Song  ;  Jae Il Shin  ;  Samuele Cortese 
Citation
 MOLECULAR PSYCHIATRY, Vol.28(12) : 5319-5327, 2023-12 
Journal Title
MOLECULAR PSYCHIATRY
ISSN
 1359-4184 
Issue Date
2023-12
MeSH
Adult ; Aged ; Cost of Illness ; Disability-Adjusted Life Years* ; Female ; Global Burden of Disease* ; Global Health* ; Humans ; Incidence ; Male ; Middle Aged ; Prevalence ; Quality-Adjusted Life Years ; Risk Factors ; Schizophrenia* / epidemiology
Abstract
Schizophrenia substantially contributes to the burden of mental disorders. Schizophrenia's burden and epidemiological estimates in some countries have been published, but updated estimates of prevalence, incidence, and schizophrenia-related disability at the global level are lacking. Here, we present the data from and critically discuss the Global Burden of Diseases, Injuries, and Risk Factors Study data, focusing on temporal changes in schizophrenia's prevalence, incidence, and disability-adjusted life years (DALYs) globally. From 1990 to 2019, schizophrenia raw prevalence (14.2 to 23.6 million), incidence (941,000 to 1.3 million), and DALYs (9.1 to 15.1 million) increased by over 65%, 37%, and 65% respectively, while age-standardized estimates remained stable globally. In countries with high socio-demographic index (SDI), both prevalence and DALYs increased, while in those with low SDI, the age-standardized incidence decreased and DALYs remained stable. The male/female ratio of burden of schizophrenia has remained stable in the overall population over the past 30 years (i.e., M/F = 1.1), yet decreasing from younger to older age groups (raw prevalence in females higher than males after age 65, with males having earlier age of onset, and females longer life expectancy). Results of this work suggest that schizophrenia's raw prevalence, incidence, and burden have been increasing since 1990. Age-adjusted estimates did not reduce. Schizophrenia detection in low SDI countries is suboptimal, and its prevention/treatment in high SDI countries should be improved, considering its increasing prevalence. Schizophrenia sex ratio inverts throughout the lifespan, suggesting different age of onset and survival by sex. However, prevalence and burden estimates for schizophrenia are probably underestimated. GBD does not account for mortality from schizophrenia (and other mental disorders, apart from anorexia nervosa).
Full Text
https://www.nature.com/articles/s41380-023-02138-4
DOI
10.1038/s41380-023-02138-4
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아과학교실) > 1. Journal Papers
Yonsei Authors
Shin, Jae Il(신재일) ORCID logo https://orcid.org/0000-0003-2326-1820
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/204720
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links